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Summary
The paper highlights the facts about the possibilities of improving the functionality of
beer with extracts of thyme (Thymus vulgaris), lemon balm (Melissa officinalis) and mush-
room Ganoderma lucidum. It briefly summarizes the most important data about possible
positive action of moderate beer consumption and the benefits of beer as a base for devel-
oping a variety of products with enhanced functionality. It gives an overview about the
mentioned herbs and the mushroom, their use in traditional medicine, chemical composi-
tion, pharmacodynamic properties and possible benefits from the brewing point of view.
Procedures for extraction of biological material, experimental results of antimicrobial prop-
erties, antioxidant capacity and sensory evaluation of beer enriched with these extracts are
given. Experimental results indicate that commercially produced and bottled pils beer en-
riched with tinctures of Thymus vulgaris and Melissa officinalis shows improved antimicro-
bial and antioxidative properties. Ganoderma is particularly important because of its unique
functional properties and sensory compatibility with beer. Products obtained like this could
fulfill several goals: developing novel beer types, developing products with health-pro-
moting properties that meet market needs and eventually gain new beer consumers. Alco-
hol content of such products depends on the type and alcohol content of initial beer.
Key words: beer, lemon balm, thyme, Ganoderma, antimicrobial, antioxidative, sensorial pro-
perties
Introduction
Beer is the oldest and one of the most used alcoholic
beverages in the world. Its huge popularity is gained not
only by low cost and easy access, but by its immense
properties and possible health benefits. Researchers con-
firm that drinking beer in moderation has beneficial ef-
fects on numerous aspects of health such as: reducing
the risk of cardiovascular disease, blood cholesterol levels,
diabetes, osteoporosis, dementia, and it can be part of a
healthy 'mass reduction' and valuable source of vitamins,
minerals and antioxidants (1). Beer as a truly natural
drink contains hundreds of different compounds (vita-
mins, minerals, amino acids, carbohydrates, organic acids,
polyphenols) necessary for good body functioning (2).
Some main components of beer are shown in Table 1 (3).
Numerous studies indicate that if consumed in mode-
rate and responsible manner, beer can act positively on
the overall health condition.
There is evidence that moderate beer consumption
can provide a significant increase of vitamin B6, B12, A
and folate intake in case of females and vitamin B2, B6,
niacin and folate in case of men (4). Beer is often quoted
as a valuable source of magnesium, potassium, phospho-
rus and silicon (5,6). All these biotics are of great impor-
tance for appropriate body functioning. Potassium helps
in elimination of sodium and chlorides from the body,
while magnesium is necessary for appropriate brain,
muscle and coronary artery functioning. It has been suc-
cessfully used in prevention and treatment of arrhythmia
and coronary diseases (7). Furthermore, magnesium con-
tributes to calcium metabolism, and good bone mineral
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density (BMD) (8–10). One litre of beer can be a source
of approx. 25–30 and even 40 % of the recommended
daily amount of magnesium and similar quantity of po-
tassium and phosphorus (10,11). Beer becomes more and
more interesting as a source of silicon as well. Recent
studies have shown that supplemental silicon has both
anti-resorptive and anabolic action on human osteoblast-
-like cells, and not only inhibits bone loss but also
increases BMD (12,13).
Beer contains important dietary fibres as well. Their
content in beer is between 0.4 and 6.2 g/L, which is
2–16 % of recommended daily intake (14,15). Moderate
consumption of beer can result in increasing HDL cho-
lesterol and suppressing LDL cholesterol and platelet ag-
gregation in the similar way as wine and other alcoholic
beverages (16). The obtained results indicate that homo-
cystein levels, responsible for damaging arteries and in-
ducing atherosclerosis, do not increase among moderate
beer drinkers (17,18). This may be due to the fact that
beer contains a large quantity of vitamin B6 and folic
acid. In the case of diabetics, the evidence from observa-
tional studies suggests that drinking beer in moderation
(6–48 g alcohol/day) can be associated with increasing
insulin sensitivity and a highly significant 30 % reduced
risk of type 2 diabetes (also called adult onset or non-
-insulin-dependent diabetes) (19–21). Furthermore, insulin
levels could be reduced, which is good for non-diabetics
because it decreases the chance of developing atheroscle-
rosis, acting as blood thinner and reducing the risk of
coronary thrombosis (22). It seems that the risk of de-
veloping kidney stones is also reduced as beer helps in
flushing the kidneys (23). Positive effect on the immune
system of healthy adults is mentioned as well (24). There
is also a question of cancer diseases. The use of alcoholic
beverages has been related to increased risks of several
cancers in humans. Threats of oral, laryngeal, esophageal
and liver cancer are elevated among drinkers, usually in
proportion to the consumed quantity (25). However, there
is evidence that some compounds in beer, mainly micro-
nutrient fractions from hops, could prevent colonic car-
cinogenesis (26). The most important biologically active
compounds found in hops are polyphenols, especially
xanthohumol (XH) and 8-prenylnaringenin (8-PN) (27,28).
Several studies have revealed that XH strongly suppress-
es one of the key enzymes in cancer development and
stimulates detoxication enzymes to repress carcinogen-
esis (29–32). 8-PN is one of the most powerful phyto-
-oestrogens found in nature. It was considered that their
action is negligible because their concentrations in beer
are generally very low, but the latest studies show that
moderate beer consumption can provide these compounds
in quantities within the range of biological activity (27,28).
Considering all these facts, it is obvious that beer has
great potential as a beverage with pharmacodynamic
action. Our aim is to improve this property with natural
materials such as medicinal herbs, namely lemon balm
and thyme and mushroom Ganoderma.
Numerous herbs have a long tradition in folk me-
dicine. For ages they have been used for curing and me-
dical purposes. Throughout the history, a lot of them were
used in the process of brewing as well, for flavouring
and masking beer deficiencies. With the introduction of
hops, this tradition has come to an end.
Lemon balm (Melissa officinalis) contains numerous bio-
active compounds: essential oils, phenolic compounds,
flavonoids and tannins. More than 190 components of
the essential oils have been described. About 50–70 % of
these oils are citral, citronellol, geraniol, caryophyllen, and
nerol. Traditionally, lemon balm was used in treatment
of insomnia, anxiety, depression, migraine, tension head-
ache, digestion-improving agents, anorexia, colic, and
Graves’ disease and other thyroid conditions (33).
Thyme (Thymus vulgaris L.) contains 1.2–2.5 % es-
sential oils, tannins, flavonoids, triterpens, phytosterols
and saponins. Essential oils contain primarily the isome-
ric monoterpen thymol. These substances are shown to
be cancer chemoprotective (33). Both herbs are on the
GRAS (generally recognized as safe) list of the World
Health Organization (WHO) and the European Scientific
Cooperative on Phytotherapy (ESCOP) (34,35).
Ganoderma lucidum is a woody mushroom often cal-
led 'Elixir of Life', 'Food for Gods' and 'Mushroom of the
Universe'. It is well known by several different names in
the world like: Ganoderma in China, Reishi in Japan and
Young Zhi in Korea. Ganoderma contains numerous natural
bioactive components, polysaccharides, ergosterols, pro-
teins, ganoderic acids, unsaturated fatty acids, vitamins
and minerals. In numerous studies it was confirmed that
Ganoderma lucidum possesses anti-cancer properties. It
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Table 1. Relative composition of beer (3)
Substance Concentration Substance Concentration
water 90–94 % potassium 200–450 mg/L
ethanol 3–5 % (by volume) sodium 20–350 mg/L
carbohydrates 1–6 % m/V calcium 25–120 mg/L
folic acid (B9) 0.04–0.60 mg/L magnesium 50–90 mg/L
pyridoxine (B6) 0.07–1.70 mg/L iron 0.01–0.30 mg/L
biotin (B8) 0.015 mg/L zinc 0.01–1.48 mg/L
riboflavin (B2) 0.02–0.10 mg/L cobalt 0.01–0.11 mg/L
pantothenic acid (B5) 0.04–2.0 mg/L chromium 0.04 mg/L
thiamin (B1) 0.08 mg/L manganese 0.03–0.20 mg/L
cyanocobalamin (B12) 0.03 mg/L silica 40–120 mg/L
niacin (B3) 0.3–5.0 mg/L total nitrogen content 300–1000 mg/L
mainly comes from polysaccharides b-glucans, located in
mycelia, the fruiting body of fungi and spores. Triter-
penoids isolated from the mushroom have antioxidative,
immunomodulating and antitumour effect. Major triter-
penoides isolated from Ganoderma mushroom are gano-
deric acids R, T, U, V, W, X, Y and Z; lucidimol A and B;
ganodermanondiol; ganoderiol F; and ganodermanon-
triol (36). It has been proven that these terpenoids have
numerous positive actions on the human body, carcino-
static effects on cancer cells, and many of them also pos-
sess anti-angiogenic activity (37,38).
The purpose of this study is to assess the potential
effects of the given herbs and mushroom for the creation
of beer with enhanced functionality. Their sensory pro-




As a requirement for this experiment dry plant herbs
Thymus vulgaris L. and Melissa officinalis were used for the
preparation of tinctures. The tinctures were prepared at
the Institute for Medicinal Plant Research Dr Josif Pan~i},
Belgrade, Serbia, using the conditions prescribed accord-
ing to European Pharmacopoeia (34). Dry herbs were cut
into pieces and mixed thoroughly with 70 % (by volume)
ethanol solvent in a drug/solvent ratio of 1:5. Extraction
was done in a percolator at a temperature of 21 °C for
24 h. The residue was pressed out and the liquid com-
bined with the percolate.
Mushroom Ganoderma lucidum tissue was cut into
pieces and mixed with an alcoholic solution of 70 % (by
volume) ethanol. Extraction was performed as a daily
mixing in a magnetic stirrer for 10 min and then allowed
to stand in a dry and dark place at room temperature.
Extraction period was 21 days. After the extraction, the
solution was filtered and concentrated in a vacuum to
1/5 of its initial content.
Bottled pils beer was used for the experiment. The
recommended daily doses of tinctures (1–1.5 mL) were
added to 0.5 L of beer in a laminar hood. After inocula-
tions, the beer samples were closed hermetically and left
to mature at 4 °C for 7 days.
Antimicrobial activity
Screening beer for antibacterial activity was done us-
ing the disk diffusion method. Antimicrobial assays were
performed on six organisms from the American Type of
Culture Collection (ATCC): Staphylococcus aureus ATCC
6538, Kocuria rhizophila (Micrococcus luteus) ATCC 9341,
Escherichia coli O157:H7 ATCC 35150, Listeria monocyto-
genes ATCC 19115, Geobacillus stearothermophilus ATCC
7953 and Candida albicans ATCC 24433. The cultures were
adjusted to approx. 105 CFU/mL with sterile saline solu-
tion. Petri dishes were inoculated with 0.2 mL of micro-
organism suspension and overlaid with 20 mL of the me-
dium. For cultivating the bacteria, Trypticase soy agar
with 0.6 % yeast extract (TSA-YE) was used. Three filter
disks (Whatman®, Sigma-Aldrich, St. Louis, MO, USA,
and Schleicher&Schuell, Dassel, Germany, 6 mm in dia-
meter) were placed on each agar and diffusion method
was performed by adding 10 µL of appropriate suspension
on each disk. Blind probe contained only 70 % C2H5OH.
Bacteria were incubated at 37 °C for 24 h and after the
incubation period, the zone of inhibition was measured.
Small sectors from the zone of inhibition were taken and
inoculated in TSA-YE for cultivated microorganisms.
Sectors in TSA-YE were incubated at 37 °C for 24 h to
see if the effect of beer was microbicidal or microbistatic
(39). Studies were performed in triplicate, and mean value
was calculated. Antimicrobial assay was performed on
the above strains using beer with lemon balm, beer with
thyme, beer with lemon balm and Ganoderma lucidum and
beer with thyme and Ganoderma lucidum.
Extract analysis
Ganoderma extract was analyzed by liquid chroma-
tography-mass spectrometry (LC/MS) method. LC/MS
analysis was performed on an Agilent MSD TOF coupled
to an Agilent 1200 series HPLC (Karlsruhe, Germany),
using Zorbax Eclipse XDB-C18 column (RR, 30×2.1 mm,
i.d. 3.5 µm). Mobile phase A was 0.2 % formic acid in
water, and mobile phase B was acetonitrile. The injec-
tion volume was 5 µL, and elution was performed at
0.7 mL/min with gradient program (0–1.5 min 5 % B,
1.5–10 min 5–95 % B, 10–15 min 95 % B, 15–16 min 99–5 %
B). Mass spectra were acquired using an Agilent electro-
spray ionization-mass spectrometric detection (ESI-MSD)
time-of-flight (TOF). Capillary voltage was 4000 V, frag-
mentor voltage 140 V, nebulizer pressure 310 kPa (45 psig),
drying gas 12 L/min, gas temperature 350 °C, mass ran-
ge 100–1500 m/z, negative and positive ionization mode.
Processing of the data was done with the software Mole-
cular Feature Extractor and Mass Profiler (Agilent Tech-
nologies Inc, Santa Clara, CA, USA).
Tinctures of Thymus vulgaris L. and Melissa officinalis
were characterized by the combination of gas chroma-
tography and mass spectrometry (GC/MS). GC/MS ana-
lyses were carried out on a Hewlett Packard, HP G1800C
(Palo Alto, CA, USA) gas chromatograph equipped with
a split/splitless injector and Agilent HP-5MS capillary
column. Individual constituents were identified by com-
paring their retention times with those of analytical
standards of available terpenoids, but also by computer
searching, matching mass spectral data with those held
in reference libraries (Wiley 275/NIST).
Antioxidant activity
Free radical scavenging ability was done using the
DPPH method. This method is based on the reduction
of a stable DPPH (2,2-diphenyl-1-picrylhydrazyl) radical
by antioxidants in a methanolic solution. In the presence
of antioxidants, the purple colour of the DPPH radical
solution changes to a bright yellow and the intensity of
this change can be monitored spectrophotometrically. The
samples were analyzed according to the method report-
ed by Brand-Williams et al. (40). Briefly, methanol DPPH
solution with buffer at pH=4.3, c(DPPH)=0.184 µM, was
added to different volumes of diluted sample and the
free radical scavenging capacity of the sample was eva-
luated by measuring the absorbance at 525 nm imme-
diately after the addition of DPPH (t=0) and after 15 min.
The results were expressed as the percentage of reduc-
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tion ('inhibition') of the DPPH (Q), which is defined by
the following equation:
Q=100·(A0–As)/A0 /1/
where A0 is the initial absorbance and As is the value of
absorbance after the reaction reached steady state. All
determinations were performed in triplicate. Antioxidant
activity was investigated in beer with thyme and beer
with lemon balm, while beer with Ganoderma showed in-
conclusive results and they need to be done over again.
Sensorial evaluation
The consumer acceptance test was carried out by 100
untrained consumers with the following average profile:
95 % were 20–25 years of age, 29 % were female, 72 %
with the consumption frequency of one or more beers
per week and 27 % were non-drinkers of beer. The beer
samples were evaluated using a 5-point scale. Consumers
did not have any formal training or experience in the
description of beer flavour. Aroma, taste, body, bitterness,
liveliness and overall impression were tested. Three beer
types were evaluated: beer with Melissa officinalis (BM),
beer with Thymus vulgaris (BT) and beer with Ganoderma
lucidum (BG) vs. initial beer (IB).
Statistical analysis
The experimental results were analyzed with the sta-
tistical package Statistica v. 6.1 (41). The data analysis of
the sensory properties was performed using Friedman
ANOVA and Wilcoxon matched pairs test.
Results and Discussion
Results of LC/MS analysis of Ganoderma lucidum,
Thymus vulgaris and Melissa oficinalis extracts are given
in Table 2. LC/MS analysis has verified that Ganoderma
extract contains biologically active terpenoids (ganoderic
acid A, B, C, D, H and J) essential for its expected phar-
macodynamic action. The composition of the tested plant
extracts, thyme and lemon balm, shows the presence
of their constituents (carvacrol, neral, thymol, geranial),
given in Table 2.
Antimicrobial activity
The antimicrobial activity of beer and beer with ex-
tracts against standard microorganisms (expressed as
zones of growth) is given in Table 3. Blind probe showed
that 70 % ethanol had no antimicrobial influence on the
investigated microorganisms. The results indicate that
initial beer (IB) even stimulates the growth of S. aureus
ATCC 6538 and E. coli O157:H7 ATCC 35150. IB showed
light microbistatic effect against K. rhizophila ATCC 9341
and L. monocytogenes ATCC 19115, while in the case of
G. stearothermophilus ATCC 7953 and C. albicans ATCC
24433, it showed no activity. Beer with Thymus vulgaris
(BT) extract had microbistatic activity against K. rhizo-
phila ATCC 934, L. monocytogenes ATCC 19115 and G.
stearothermophilus ATCC 795, whereas towards S. aureus
ATCC 6538, E. coli O157:H7 ATCC 35150 and C. albicans
ATCC 24433, it showed no activity. Beer enriched with
Melissa oficinalis (BM) did not indicate any activity against
K. rhizophila ATCC 9341, E. coli O157:H7 ATCC 35150, G.
stearothermophilus ATCC 7953 or C. albicans ATCC 24433,
but it showed microbistatic activity against L. monocyto-
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Table 2. Relative content of constituents in Ganoderma lucidum, thyme and lemon balm extracts
Constituents RT/MS Bruto molecular formulae RRI
Ganoderma lucidum ganoderic acid E 4.575 C37H36O2, C30H40O7 512.2
ganoderic acid G 4.721 C30H44O8 532.3
ganoderic acid B, A 4.821 C30H44O7 516.3
ganoderic acid C, D, J 5.209 C30H42O7 514.2
ganoderic acid H 5.549 C32H44O9 572.2
ganoderic acid F 6.163 C32H42O9 570.2
ganodermanontriol, lucidumol A 7.389 C30H48O4 472.3
Melissa oficinalis coumaran 16.842 C9H6O2 1223.0
geranial 17.174 C10H16O 1238.3
neral 17.685 C10H16O 1268.1
thymol 18.698 C10H14O 1299.8
carvacrol 19.765 C11H14O 1312.5
Thymus vulgaris thymol 19.505 C10H14O 1292.1
carvacrol 19.774 C11H14O 1300.0
vinylguaiacol 20.087 C9H10O2 1309.5
syringol 21.369 C8H10O3 1349.4
eugenol 21.495 C10H12O2 1353.0
RT/MS – identification by GC retention times (RT) and mass spectrometry (MS) of authentic compounds, RRI – relative retention index
genes ATCC 19115 and stimulation in the case of S. aureus
ATCC 6538. Results of antimicrobial activity of beer sam-
ples with both thyme and Ganoderma (BTG) and beer with
lemon balm and Ganoderma (BMG) showed no activity
against S. aureus ATCC 6538, E. coli O157:H7 ATCC
35150 and C. albicans ATCC 24433, while in the case of L.
monocytogenes ATCC 19115, both BTG and BMG exerted
inhibitory effect. Compared to IB, the highest antibac-
terial activity was expressed by BMG when applied on
K. rhizophila ATCC 9341 and BT on G. stearothermophilus
ATCC 7953 strain. IB showed even upgrowth on S. au-
reus ATCC 6538 and E. coli O157:H7 ATCC 35150, but all
other samples showed no activity. There was no stimu-
lation, except in the case of BM on S. aureus ATCC 6538,
which means that all other beers slowed down the up-
growth of the above strains.
Antioxidant activity
Antioxidant activity was determined in IB, BT and
BM using DPPH method by calculating the IC50. Anti-
radical activity was determined as the quantity of anti-
oxidant required to reduce the initial DPPH concentra-
tion by 50 %. For each tested antioxidant concentration,
graphs were plotted and presented (Figs. 1 and 2). The
analyzed beer showed evident antioxidant activity. DPPH
radical scavenging was concentration-dependent, with
IC50=7.2 µL/mL for IB, IC50=3.3 µL/mL for BT and
IC50=5.4 µL/mL for BM. The lower number signifies the
higher antioxidant potential in beer. DPPH analysis sug-
gests that IB has significantly lower antioxidant poten-
tial than BM and BT.
Sensory evaluation
The results of sensorial evaluation of the tested sam-
ples are presented by means of statistical computation.
As it was expected, different tasters judged the beer
samples and analyzed sensorial parameters in relatively
different ways. Grades were in the range from 1.0 to 5.0.
The lowest grade (1.0) was given for the bitterness of IB,
and 1.5 for the aroma of BM and BT. The lowest score
for all other sensorial parameters in all tested beer samples
was 2.0. Maximum grade for all tested parameters and
beer samples was 5.0. The spider diagrams of the ob-
tained sensorial properties and overall impression of the
tested beer samples are given in Figs. 3–5.
Tasters characterized IB as refreshing with an em-
phasized aroma. They agreed that the body was poor
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Fig. 1. Inhibitory effect of initial beer and beer with lemon balm
on the DPPH radical
Fig. 2. Inhibitory effect of initial beer and beer with thyme on the
DPPH radical
Table 3. Zones of growth (in mm) for selected beers
Microorganism IB BT BM BTG BMG
S. aureus ATCC 6538 10.00* – 8.50* – –
K. rhizophila ATCC 9341 1.50† 2.00† – – 10.00†
E. coli O157:H7 ATCC 35150 3.00* – – – –
L. monocytogenes ATCC 19115 3.33† 5.00† 6.60† 4.33† 8.00†
G. stearothermophilus ATCC 7953 – 10.00† – 3.00† –
C. albicans ATCC 24433 – – – – –
Values for the zones of growth inhibition are presented as mean values; IB – initial beer, BT – beer with thyme, BM – beer with lemon
balm, BTG – beer with thyme and Ganoderma, BMG-beer with lemon balm and Ganoderma; * stimulation, † inhibition, – no activity
Fig. 3. Mean values of sensory parameters of initial beer and beer
with lemon balm
and bitterness was overpowering. Compared with IB, they
found that BT was very specific beer with unusual but
pleasant aroma and taste. It was sweeter than other beers
and a bit spicy. BM was weak in bitterness and poor in
body, while BG was characterized as great, refreshing
with pleasant bitterness. It was definitely well accepted.
According to the mean grades, it was evaluated simil-
arly or better than the initial commercially produced
pils beer. On the other hand, BM and BT showed good
results in liveliness and body. However, more reliable
data can be obtained only by further statistical analysis.
According to Friedman ANOVA, tasters evaluated the
analyzed beers as statistically significantly different in
liveliness (c2=10.961; p=0.012), and statistically highly
significant difference in flavour (c2=23.634; p<0.01), taste
(c2=16.724; p<0.01), fullness (c2=20.813; p<0.01), bitter-
ness (c2=32.287; p<0.01) and overall impression (c2=25.848;
p<0.01). We found differences in sensory properties main-
ly as the result of differences between the beers with
added medicinal herbs, and not differences between the
initial beer and beer with medicinal herbs. According to
the results of the Wilcoxon matched pairs test (Table 4),
IB has a statistically significantly better aroma than BM,
and significantly better aroma and taste than BT.
BG, compared to IB, is statistically significantly bet-
ter in the average score for bitterness and even better for
body. The general impression is that BG has the same
sensory quality as IB, whereas BM and BT are statisti-
cally significantly inferior to IB.
Male tasters assessed that the difference between the
four analyzed types of beer was statistically highly sig-
nificant according to all sensory parameters, as well as
in the general impression. On the contrary, female tas-
ters concluded that the analyzed beers were statistically
not significantly different in body or liveliness, but sta-
tistically significantly different in taste and overall im-
pression, while the difference in aroma and bitterness
was statistically highly significant (Table 5).
Male tasters rated BG statistically significantly even
better than IB in all tested sensory characteristics and
overall impression, except liveliness, for which the aver-
age grade was statistically significantly better. The tas-
ters from this group ranked IB statistically significantly
better than BM in overall impression and statistically even
better in liveliness (Table 6). Women tasters specified that
the aroma of IB was statistically significantly better than
the aroma of BG, and statistically even better than BM.
Furthermore, BT was marked with significantly lower
average grade compared to the IB in terms of aroma,
taste and bitterness (Table 6). It is noticeable that the
two main groups of tasters mainly disagreed in evalu-
ation of analyzed beers. Male tasters preferred full-bodied
beers with distinguished bitterness, opposed to female
tasters, who preferred more refreshing, light and drink-
able beers. Both groups showed their interest in these
types of beverages as a valuable source of nutrients, but
their main concern was alcohol content.
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Fig. 4. Mean values of sensory parameters of initial beer and beer
with Ganoderma
Fig. 5. Mean values of sensory parameters of initial beer and beer
with thyme
Table 4. Results of Wilcoxon matched pairs test – comparison of sensory properties of initial beer to the beer with lemon balm, beer
with Ganoderma and beer with thyme
Sensorial properties
and overall impression
Beer with lemon balm Beer with Ganoderma Beer with thyme
z p z p z p
aroma 3.834 0.000 0.334 0.739 2.082 0.037
taste 1.886 0.059 1.504 0.133 2.456 0.014
body 0.281 0.779 3.476 0.001 0.494 0.621
bitterness 1.601 0.109 1.975 0.048 1.330 0.184
liveliness 1.352 0.176 1.188 0.235 1.452 0.146
overall impression 2.562 0.011 1.813 0.070 2.119 0.034
p<0.05 statistically significantly different, p<0.01 statistically highly significant difference
Conclusions
The purpose of this study was to determine some
functional properties and sensorial acceptability of new
types of special beers with improved health benefits. Ex-
perimental results indicate that commercially produced
and bottled pils beer enriched with tinctures of Thymus
vulgaris (thyme), Melissa officinalis (lemon balm) and Ga-
noderma lucidum show improved antimicrobial and anti-
oxidative properties and are sensorially acceptable. Beer
enriched with the tincture of Thymus vulgaris has evident
microbistatic potential against L. monocytogenes ATCC
19115. The same beer enriched with the tincture of Me-
lissa officinalis showes significant microbistatic potential
against G. stearothermophilus ATCC 7953. Antioxidant
capacity of the beer enriched with lemon balm and
especially with thyme was obviously improved. In the
case of beer with thyme, antioxidant capacity was twice
as high as in initial pils beer. Ganoderma obviously has
great potential of sensory compatibility with beer. The
evaluation of bitterness is especially promising, as Gano-
derma is well known for its bitter taste, mostly because
of its terpenoids. Well accepted bitter taste of beer with
Ganoderma suggests that higher doses of the extract can
be taken into account. Sensory results of beer with thyme
and lemon balm were rather disappointing. Our previous
results with the same herbs, but in lower doses, were
much more promising (33). It is obvious that the doses
of extracts and the combination of herbs are of great im-
portance. A lot of medicinal herbs can be used for fla-
vouring, adjustment of sensory properties and affinities
of different target groups of consumers.
The obtained results indicate that the herbs with long
tradition in folk medicine can be very interesting raw
materials for brewing industry. A variety of different beers
with defined functional properties can be produced, creat-
ed for special purposes and target groups. Alcohol content
of such products depends on the type of initial beer,
meaning that using alcohol-free beers even functional
drinks can be created. Such products could fulfill several
goals: developing novel beer products, developing pro-
ducts with health-promoting properties that meet the
market needs and eventually gain new beer consumers.
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Table 5. Results of Friedman ANOVA test according to the gender of tasters
Sensorial properties and overall impression Male Female
c
2 p c2 p
aroma 17.070 0.001 15.673 0.000
taste 16.506 0.001 7.831 0.049
body 30.361 0.000 3.707 0.294
bitterness 24.070 0.000 18.221 0.000
liveliness 17.962 0.000 5.768 0.123
overall impression 28.134 0.000 11.003 0.012
p<0.05 statistically significantly different, p<0.01 statistically highly significant difference
Table 6. Results of Wilcoxon matched pairs test for sensorial properties of initial beer, compared to the beer with lemon balm, beer
with Ganoderma and beer with thyme according to the gender of tasters
Gender Sensorial properties
and overall impression
Beer with lemon balm Beer with Ganoderma Beer with thyme
z p z p z p
Male aroma 1.894 0.058 2.984 0.003 0.817 0.414
taste 1.329 0.184 3.733 0.000 1.224 0.221
body 1.213 0.225 3.771 0.000 0.373 0.709
bitterness 0.130 0.897 3.711 0.000 0.614 0.539
liveliness 2.642 0.008 2.294 0.022 0.257 0.797
overall impression 2.222 0.026 3.650 0.000 1.049 0.294
Female aroma 3.358 0.001 1.976 0.048 1.985 0.047
taste 1.385 0.166 0.125 0.900 2.090 0.037
body 0.292 0.770 1.802 0.072 0.359 0.720
bitterness 1.855 0.064 0.111 0.912 1.998 0.046
liveliness 0.114 0.909 0.164 0.870 1.589 0.112
overall impression 1.612 0.107 0.087 0.930 1.848 0.065
p<0.05 statistically significantly different, p<0.01 statistically highly significant difference
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